| Nom du produit | Dapagliflozin |
|---|---|
| Numéro CAS | 461432-26-8 |
| Formule moléculaire | C21H25ClO6 |
| Poids moléculaire | 408.87 |
| Apparence | Poudre cristalline blanche à blanc cassé |
| Essai (HPLC) | ≥98% |
| Perte au séchage | ≤0.5% |
| Résidu au feu | ≤0.1% |
| Métaux lourds | ≤ 10 ppm |
| Point de fusion | 196-200°C |
| Rotation spécifique | [α]D20 = +30° to +34° (c=1, methanol) |
Besoin d'aide ? Contacter notre équipe

Synonymes
- Dapagliflozin propanediol, BMS-512148, Farxiga, Forxiga, (1S)-1,5-anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-D-glucitol
Dapagliflozin is one of the most prescribed SGLT2 inhibitors worldwide — and for good reason. It works by blocking glucose reabsorption in the kidneys, letting excess sugar flush out through urine. That mechanism not only lowers blood glucose in type 2 diabetes patients but also delivers bonus effects like modest weight loss and blood pressure reduction. For formulators, it’s a solid choice for building combination therapies or standalone products in the fast-growing diabetes and metabolic health market.
We supply dapagliflozin as a high-purity crystalline powder, manufactured under controlled conditions and rigorously tested. Every batch is shipped with a full COA, and we offer flexible quantities — from R&D samples to bulk production — with reliable global logistics.
Room,5-0203, Courtyard 205, Lianhu District,Xi'an,Shaanxi,China